|Bid||3.4000 x 1000|
|Ask||4.2000 x 1000|
|Day's range||3.7300 - 4.1800|
|52-week range||1.1000 - 6.6000|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||25 Feb 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||3.75|
Image source: The Motley Fool. NantHealth, Inc. Common Stock (NASDAQ: NH)Q4 2020 Earnings CallFeb 25, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood afternoon, ladies and gentlemen, and welcome to the NantHealth 2020 fourth-quarter and full-year financial results conference call.
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help transform complex data into actionable insights, today reported financial results for its fourth quarter and full year ended December 31, 2020.
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2020 fourth quarter and full year on Thursday, February 25, 2021, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.